Syndax Pharmaceuticals Inc (SNDX) — Cash Flow Reinvestment Rate
Syndax Pharmaceuticals Inc (SNDX) has a Cash Flow Reinvestment Rate of 0.60x as of December 2021, reinvesting $59.96 Million (capex $129.00K plus investments $-59.83 Million) from operating cash flow of $100.71 Million. Check Syndax Pharmaceuticals Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Syndax Pharmaceuticals Inc Cash Flow Reinvestment Rate (2021–2021)
Historical reinvestment intensity for Syndax Pharmaceuticals Inc across 1 annual periods. Explore Syndax Pharmaceuticals Inc (SNDX) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Syndax Pharmaceuticals Inc (2021–2021)
Year-by-year capital reinvestment analysis for Syndax Pharmaceuticals Inc. For live market cap and broader valuation context, see how much is Syndax Pharmaceuticals Inc worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 1.40x | $40.87 Million | $29.13 Million | $129.00K | — |